Eupraxia OTC Stock Buy Hold or Sell Recommendation

EPRXF
 Stock
  

USD 0.85  0.0017  0.20%   

Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Eupraxia Pharmaceuticals is 'Not Rated'. Macroaxis provides Eupraxia Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EPRXF positions. The advice algorithm takes into account all of Eupraxia Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Eupraxia Pharmaceuticals' buy-and-hold perspective. Continue to Eupraxia Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Eupraxia and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Eupraxia Pharmaceuticals.

Execute Eupraxia Pharmaceuticals Buy or Sell Advice

The Eupraxia recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Eupraxia Pharmaceuticals. Macroaxis does not own or have any residual interests in Eupraxia Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Eupraxia Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Eupraxia PharmaceuticalsBuy Eupraxia Pharmaceuticals
Strong Sell

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Not Available
Details

Reporting Quality (M-Score)

Details
For the selected time horizon Eupraxia Pharmaceuticals has a Mean Deviation of 0.8346, Standard Deviation of 3.44 and Variance of 11.85
We provide trade advice to complement the prevailing expert consensus on Eupraxia Pharmaceuticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Eupraxia Pharmaceuticals is not overpriced, please confirm all Eupraxia Pharmaceuticals fundamentals, including its price to book, total debt, as well as the relationship between the Total Debt and earnings per share . As Eupraxia Pharmaceuticals appears to be a penny stock we also advise to verify its cash per share numbers.

Eupraxia Pharmaceuticals Trading Alerts and Improvement Suggestions

Eupraxia Pharmaceuticals generated a negative expected return over the last 90 days
Eupraxia Pharmaceuticals has some characteristics of a very speculative penny stock
Eupraxia Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (17.82 M).
Eupraxia Pharmaceuticals has accumulated about 25.9 M in cash with (14.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.21, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 13.0% of the company shares are held by company insiders
Latest headline from investingnews.com: Cybin to Participate in Upcoming Scientific and Investor Conferences - Investing News Network

Eupraxia Pharmaceuticals Returns Distribution Density

The distribution of Eupraxia Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Eupraxia Pharmaceuticals' future price movements. The chart of the probability distribution of Eupraxia Pharmaceuticals stock daily returns describes the distribution of returns around its average expected value. We use Eupraxia Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Eupraxia Pharmaceuticals returns is essential to provide solid investment advice for Eupraxia Pharmaceuticals.
Mean Return-0.42Value At Risk0.00
Potential Upside0.00Standard Deviation3.44
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Eupraxia Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Eupraxia Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Eupraxia Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Eupraxia Pharmaceuticals' price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Eupraxia otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.47
β
Beta against DOW-0.58
σ
Overall volatility
0.00
Ir
Information ratio -0.11

Eupraxia Pharmaceuticals Volatility Alert

Eupraxia Pharmaceuticals exhibits very low volatility with skewness of -8.12 and kurtosis of 66.0. However, we advise investors to further study Eupraxia Pharmaceuticals technical indicators to ensure that all market info is available and is reliable. Eupraxia Pharmaceuticals is a potential penny stock. Although Eupraxia Pharmaceuticals may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Eupraxia Pharmaceuticals. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Eupraxia instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Eupraxia Pharmaceuticals Fundamentals Vs Peers

Comparing Eupraxia Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Eupraxia Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Eupraxia Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Eupraxia Pharmaceuticals or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Eupraxia Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Eupraxia Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Eupraxia Pharmaceuticals to competition
FundamentalsEupraxia PharmaceuticalsPeer Average
Return On Equity(89.03) %(0.31) %
Return On Asset(34.29) %(0.14) %
Current Valuation1.19 M16.62 B
Shares Outstanding14.24 M571.82 M
Shares Owned by Insiders12.61 %10.09 %
Shares Owned by Institutions16.63 %39.21 %
Price to Book0.51 X9.51 X
EBITDA(16.32 M)3.9 B
Net Income(17.82 M)570.98 M
Cash and Equivalents25.9 M2.7 B
Cash per Share1.21 X5.01 X
Total Debt9.77 M5.32 B
Debt to Equity0.60 %48.70 %
Current Ratio21.10 X2.16 X
Book Value Per Share1.66 X1.93 K
Cash Flow from Operations(14.15 M)971.22 M
Earnings Per Share(1.47) X3.12 X
Number of Employees1918.84 K
Market Capitalization12.13 M19.03 B
Z Score0.68.72

About Eupraxia Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Eupraxia Pharmaceuticals? Buying financial instruments such as Eupraxia OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Eupraxia Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Housewares Thematic Idea Now

Housewares
Housewares Theme
Companies making housewares accessories and providing houseware services. The Housewares theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Housewares Theme or any other thematic opportunities.
View All  Next Launch
Continue to Eupraxia Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for analysis

When running Eupraxia Pharmaceuticals price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Is Eupraxia Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eupraxia Pharmaceuticals. If investors know Eupraxia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eupraxia Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Eupraxia Pharmaceuticals is measured differently than its book value, which is the value of Eupraxia that is recorded on the company's balance sheet. Investors also form their own opinion of Eupraxia Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eupraxia Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eupraxia Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eupraxia Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eupraxia Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Eupraxia Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eupraxia Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.